Atai Life Sciences
ATAI • NASDAQ
Atai Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Srinivas G. Rao, with a market cap of $1.2B.
CEOSrinivas G. Rao
Next Earnings
Upcoming earnings announcement for Atai Life Sciences
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (5:43 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Revenue Estimate
$90.9K
Earnings History
Past 12 earnings reports for Atai Life Sciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Q4 2025 | -$1.73Est: -$0.12 | -1341.7% | $1.1MEst: $737.5K | +44.5% | — |
| Mar 6, 2026 | Q2 2026 | — | — | — | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.28Est: -$0.12 | -133.3% | $749.0KEst: $55.6K | +1248.1% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.14Est: -$0.12 | -16.7% | $719.0K | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.15Est: -$0.18 | +16.7% | $1.6M | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.24Est: -$0.15 | -60.0% | -$5.0KEst: $250.0K | -102.0% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.16Est: -$0.16 | 0.0% | $40.0K | — | 10-Q/A |
| Aug 13, 2024 | Q2 2024 | -$0.36Est: -$0.16 | -125.0% | $273.0K | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.17Est: -$0.18 | +5.6% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.12Est: -$0.16 | +25.0% | $18.0KEst: $190.0K | -90.5% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.14Est: -$0.20 | +30.0% | $87.0K | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.21Est: -$0.21 | 0.0% | $172.0KEst: $10.0K | +1620.0% | 10-Q |